Literature DB >> 11781700

Familial defective apolipoprotein B-100 in a group of hypercholesterolaemic patients in Poland. Identification of a new mutation Thr3492Ile in the apolipoprotein B gene.

M Bednarska-Makaruk1, M Bisko, M F Pulawska, D Hoffman-Zacharska, M Rodo, M Roszczynko, A Solik-Tomassi, G Broda, M Polakowska, A Pytlak, H Wehr.   

Abstract

The prevalence of the familial defective apolipoprotein B-100 (FDB) Arg3500Gln mutation in 525 unrelated hypercholesterolaemic Polish subjects was evaluated. DNA samples were screened for FDB mutation using SSCP method. Presence of mutation was confirmed using a mismatch MspI PCR strategy. Plasma lipid levels and clinical characteristics of 13 patients identified as carriers of the mutation and of their 23 affected relatives were analysed and compared with non-affected ones. In the affected individuals a variable expression of lipid concentrations and of atherosclerosis symptoms were observed. The prevalence of FDB Arg3500Gln mutation in hypercholesterolaemic Polish subjects (3.7%) seems to be similar to the frequency reported in other Caucasian hypercholesterolaemic populations. The estimated prevalence of the mutation in general Polish population is relatively high being 1/250. The same haplotype at the apoB locus in the carriers of this mutation in Poland as in other populations from Western Europe suggests its common origin. In one hypercholesterolaemic subject a non-hitherto described mutation was identified. It consisted in C-->T transition in apoB codon 3492 leading to threonine to isoleucine substitution in 3492 position of apoB gene (Thr3492Ile).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11781700     DOI: 10.1038/sj.ejhg.5200720

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  5 in total

1.  Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.

Authors:  M Chmara; B Wasag; M Zuk; J Kubalska; A Wegrzyn; M Bednarska-Makaruk; E Pronicka; H Wehr; J C Defesche; A Rynkiewicz; J Limon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

Review 2.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

3.  Association of polymorphisms at restriction enzyme recognition sites of apolipoprotein B and E gene with dyslipidemia in children undergoing primary nephrotic syndrome.

Authors:  Peng Hu; Yuan Han Qin; Cheng Xue Jing; Feng Ying Lei; Ping Chen; Ming Fang Li
Journal:  Mol Biol Rep       Date:  2008-05-30       Impact factor: 2.316

4.  The genetic spectrum of familial hypercholesterolemia in south-eastern Poland.

Authors:  Mahtab Sharifi; Małgorzata Walus-Miarka; Barbara Idzior-Waluś; Maciej T Malecki; Marek Sanak; Ros Whittall; Ka Wah Li; Marta Futema; Steve E Humphries
Journal:  Metabolism       Date:  2015-11-10       Impact factor: 8.694

Review 5.  Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.

Authors:  Ivan Pećin; Merel L Hartgers; G Kees Hovingh; Ricardo Dent; Željko Reiner
Journal:  Eur J Prev Cardiol       Date:  2017-06-23       Impact factor: 7.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.